![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
Reset all filters
01 7Rocaltrol
Main Therapeutic Indication : Hormonal Disorders
Currency : USD
2020 Revenue in Millions : 32
2019 Revenue in Millions : 34
Growth (%) : -6
Main Therapeutic Indication : Hormonal Disorders
Currency : USD
2021 Revenue in Millions : 27
2020 Revenue in Millions : 32
Growth (%) : -6
Main Therapeutic Indication : Endocrinology
Currency : USD
2022 Revenue in Millions : 23
2021 Revenue in Millions : 27
Growth (%) : -13
Main Therapeutic Indication : Endocrinology
Currency : USD
2023 Revenue in Millions : 20
2022 Revenue in Millions : 23
Growth (%) : -6
Main Therapeutic Indication : Hormonal Disorders
Currency : USD
2017 Revenue in Millions : 39
2016 Revenue in Millions : 40
Growth (%) : -2
Main Therapeutic Indication : Hormonal Disorders
Currency : USD
2018 Revenue in Millions : 34
2017 Revenue in Millions : 37
Growth (%) : -7%
Main Therapeutic Indication : Hormonal Disorders
Currency : USD
2019 Revenue in Millions : 33
2018 Revenue in Millions : 35
Growth (%) : -5
LOOKING FOR A SUPPLIER?